Adding Chemotherapy to Radiotherapy Not Associated with Improved OS for Patients with Intermediate-Risk Cervical Cancer By Ogkologos - April 7, 2025 784 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a cohort study conducted at Commission on Cancer accredited centres across the US Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR The Childhood Cancer Data Initiative: Transforming the Pediatric Cancer Landscape through... August 15, 2019 EMA Recommends Extension of Therapeutic Indications for Nivolumab July 1, 2021 Screen-Detected Colorectal Cancers Have a More Favourable Stage Distribution than Colorectal... May 20, 2022 EMA Recommends Granting a Conditional Marketing Authorisation for Pemigatinib February 1, 2021 Load more HOT NEWS Survivors of Childhood Cancer are at Excess Risk of Late Mortality... A recipe for hydration! Though the Pandemic Has Slowed, Many Are Still Struggling to Put... How Fatty Liver Disease Helps Cancer Thrive in the Liver
